Med Ed Report briefs: January 2014

Eric Peterson
Eric Peterson

CME should not be industry supported, said Pew Charitable Trust as part of a 15-point conflict-of-interest proposal to ban or severely restrict interactions with industry. Proponents of physician education reacted negatively to Pew's report. The CME Coalition cited an absence of data that commercial support manifests any negative impact on outcomes.

Haymarket Medical Education won the award for outstanding collaboration from the Alliance for CE in the Health Professions. HME worked with Presbyterian Novant Heart & Wellness and data analysis firm Intelligent Medical Decisions on the type 2 diabetes activity. (Haymarket Media publishes MM&M.)

Eric Peterson, EdM, FACEHP, CCMEP, joined the American Academy of Physician Assistants as senior director, performance improvement CME. He was formerly VP, educational strategy and grant development for Annenberg Center for Health Sciences at Eisenhower Medical Center.

Physicians Interactive is expanding its CME content partnership with Oakstone Publishing, firms said, granting PI's Skyscape digital and mobile subscribers access to multimedia resources from Oakstone, an accredited med-ed provider.

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.